Center for Vulvovaginal Disorders

Quick facts

Marketed products

• clobetasol 0.05% cream
• Intrarosa · Immunology

Phase 2 pipeline

• Ketotifen Fumarate 0.25% Cream
• Peri-urethral and clitoral injections
• pimecrolimus and clobetasol

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Center for Vulvovaginal Disorders portfolio CI brief
• Center for Vulvovaginal Disorders pipeline updates RSS

Frequently asked questions about Center for Vulvovaginal Disorders

Related

• clobetasol 0.05% cream
• Intrarosa · Immunology
• Sector hub: All tracked pharma companies